A photoactivatable antibody-Chlorin e6 conjugate enabling singlet oxygen production for tumor-targeting photodynamic therapy

Photodynamic therapy is a new technology for disease diagnosis and treatment in modern medical clinics. The main advantages of photodynamic therapy are low toxicity and side effects, a wide range of applications, no drug resistance, and no obvious trauma in the treatment process. However, to achieve...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biomedical materials (Bristol) 2021-07, Vol.16 (4), p.45003
Hauptverfasser: Pan, Qi, Li, Kaixuan, Cheng, Xiaoyi, Chen, Lin, Yu, Qi, Fan, HengXin, Zheng, Liang, Yang, Zihua, Ni, Feng
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 4
container_start_page 45003
container_title Biomedical materials (Bristol)
container_volume 16
creator Pan, Qi
Li, Kaixuan
Cheng, Xiaoyi
Chen, Lin
Yu, Qi
Fan, HengXin
Zheng, Liang
Yang, Zihua
Ni, Feng
description Photodynamic therapy is a new technology for disease diagnosis and treatment in modern medical clinics. The main advantages of photodynamic therapy are low toxicity and side effects, a wide range of applications, no drug resistance, and no obvious trauma in the treatment process. However, to achieve effective photodynamic therapy, new photosensitizer carriers need to be constructed, which can selectively deliver photosensitizers into tumor tissues. In this work, a photoactivatable antibody-Chlorin e6 conjugate with a dual-function to target tumor tissue and realize cancer photodynamic therapy is constructed. Both and experiments indicate that the antibody-Chlorin e6 conjugate has the ability to target tumors rapidly and efficiently, and has the ability to generate reactive oxygen species and kill tumor cells. Overall, this photoactivable antibody-Chlorin e6 conjugate may provide a promising strategy to address the current challenges of cancer photodynamic therapy.
doi_str_mv 10.1088/1748-605X/ab9f57
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2417393502</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2417393502</sourcerecordid><originalsourceid>FETCH-LOGICAL-c341t-d96a48b39e145058aa868fe99618942d0034185cdfd698fb5f75040b46bc03a13</originalsourceid><addsrcrecordid>eNo9kM1LwzAYh4MoTqd3T5Kjl7qk-WhyHMMvGHhR8BbSNu062mQmqVjwj7d1c5ckhOf3e18eAG4wusdIiAXOqEg4Yh8LncuKZSfg4vh1enxTPAOXIWwRYpIReQ5mJGWCppxfgJ8l3G1cdLqIzZeOOm8N1DY2uSuHZLVpnW8sNBwWzm77WkcDjR2hxtYwjEdrInTfQ20s3HlX9mOLs7ByHsa-cz6J2tcmTvTflHKwumsKGDfG691wBc4q3QZzfbjn4P3x4W31nKxfn15Wy3VSEIpjUkquqciJNJgyxITWgovKSMmxkDQtERoxwYqyKrkUVc6qjCGKcsrzAhGNyRzc7XvHHT97E6LqmlCYttXWuD6olOKMSMJQOqJojxbeheBNpXa-6bQfFEZqcq4mqWoSrPbOx8jtob3PO1MeA_-SyS-fQIAk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2417393502</pqid></control><display><type>article</type><title>A photoactivatable antibody-Chlorin e6 conjugate enabling singlet oxygen production for tumor-targeting photodynamic therapy</title><source>MEDLINE</source><source>IOP Publishing Journals</source><source>Institute of Physics (IOP) Journals - HEAL-Link</source><creator>Pan, Qi ; Li, Kaixuan ; Cheng, Xiaoyi ; Chen, Lin ; Yu, Qi ; Fan, HengXin ; Zheng, Liang ; Yang, Zihua ; Ni, Feng</creator><creatorcontrib>Pan, Qi ; Li, Kaixuan ; Cheng, Xiaoyi ; Chen, Lin ; Yu, Qi ; Fan, HengXin ; Zheng, Liang ; Yang, Zihua ; Ni, Feng</creatorcontrib><description>Photodynamic therapy is a new technology for disease diagnosis and treatment in modern medical clinics. The main advantages of photodynamic therapy are low toxicity and side effects, a wide range of applications, no drug resistance, and no obvious trauma in the treatment process. However, to achieve effective photodynamic therapy, new photosensitizer carriers need to be constructed, which can selectively deliver photosensitizers into tumor tissues. In this work, a photoactivatable antibody-Chlorin e6 conjugate with a dual-function to target tumor tissue and realize cancer photodynamic therapy is constructed. Both and experiments indicate that the antibody-Chlorin e6 conjugate has the ability to target tumors rapidly and efficiently, and has the ability to generate reactive oxygen species and kill tumor cells. Overall, this photoactivable antibody-Chlorin e6 conjugate may provide a promising strategy to address the current challenges of cancer photodynamic therapy.</description><identifier>ISSN: 1748-6041</identifier><identifier>EISSN: 1748-605X</identifier><identifier>DOI: 10.1088/1748-605X/ab9f57</identifier><identifier>PMID: 32584266</identifier><language>eng</language><publisher>England</publisher><subject>Animals ; Apoptosis - drug effects ; B7-H1 Antigen - metabolism ; Cell Line ; Chlorophyllides - chemistry ; Chlorophyllides - pharmacokinetics ; Female ; HCT116 Cells ; Humans ; Immunoconjugates - chemistry ; Immunoconjugates - pharmacokinetics ; Mice ; Mice, Nude ; Optical Imaging ; Photochemotherapy - methods ; Singlet Oxygen - metabolism ; Singlet Oxygen - pharmacology</subject><ispartof>Biomedical materials (Bristol), 2021-07, Vol.16 (4), p.45003</ispartof><rights>Creative Commons Attribution license.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c341t-d96a48b39e145058aa868fe99618942d0034185cdfd698fb5f75040b46bc03a13</citedby><cites>FETCH-LOGICAL-c341t-d96a48b39e145058aa868fe99618942d0034185cdfd698fb5f75040b46bc03a13</cites><orcidid>0000-0001-8542-0925</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32584266$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pan, Qi</creatorcontrib><creatorcontrib>Li, Kaixuan</creatorcontrib><creatorcontrib>Cheng, Xiaoyi</creatorcontrib><creatorcontrib>Chen, Lin</creatorcontrib><creatorcontrib>Yu, Qi</creatorcontrib><creatorcontrib>Fan, HengXin</creatorcontrib><creatorcontrib>Zheng, Liang</creatorcontrib><creatorcontrib>Yang, Zihua</creatorcontrib><creatorcontrib>Ni, Feng</creatorcontrib><title>A photoactivatable antibody-Chlorin e6 conjugate enabling singlet oxygen production for tumor-targeting photodynamic therapy</title><title>Biomedical materials (Bristol)</title><addtitle>Biomed Mater</addtitle><description>Photodynamic therapy is a new technology for disease diagnosis and treatment in modern medical clinics. The main advantages of photodynamic therapy are low toxicity and side effects, a wide range of applications, no drug resistance, and no obvious trauma in the treatment process. However, to achieve effective photodynamic therapy, new photosensitizer carriers need to be constructed, which can selectively deliver photosensitizers into tumor tissues. In this work, a photoactivatable antibody-Chlorin e6 conjugate with a dual-function to target tumor tissue and realize cancer photodynamic therapy is constructed. Both and experiments indicate that the antibody-Chlorin e6 conjugate has the ability to target tumors rapidly and efficiently, and has the ability to generate reactive oxygen species and kill tumor cells. Overall, this photoactivable antibody-Chlorin e6 conjugate may provide a promising strategy to address the current challenges of cancer photodynamic therapy.</description><subject>Animals</subject><subject>Apoptosis - drug effects</subject><subject>B7-H1 Antigen - metabolism</subject><subject>Cell Line</subject><subject>Chlorophyllides - chemistry</subject><subject>Chlorophyllides - pharmacokinetics</subject><subject>Female</subject><subject>HCT116 Cells</subject><subject>Humans</subject><subject>Immunoconjugates - chemistry</subject><subject>Immunoconjugates - pharmacokinetics</subject><subject>Mice</subject><subject>Mice, Nude</subject><subject>Optical Imaging</subject><subject>Photochemotherapy - methods</subject><subject>Singlet Oxygen - metabolism</subject><subject>Singlet Oxygen - pharmacology</subject><issn>1748-6041</issn><issn>1748-605X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kM1LwzAYh4MoTqd3T5Kjl7qk-WhyHMMvGHhR8BbSNu062mQmqVjwj7d1c5ckhOf3e18eAG4wusdIiAXOqEg4Yh8LncuKZSfg4vh1enxTPAOXIWwRYpIReQ5mJGWCppxfgJ8l3G1cdLqIzZeOOm8N1DY2uSuHZLVpnW8sNBwWzm77WkcDjR2hxtYwjEdrInTfQ20s3HlX9mOLs7ByHsa-cz6J2tcmTvTflHKwumsKGDfG691wBc4q3QZzfbjn4P3x4W31nKxfn15Wy3VSEIpjUkquqciJNJgyxITWgovKSMmxkDQtERoxwYqyKrkUVc6qjCGKcsrzAhGNyRzc7XvHHT97E6LqmlCYttXWuD6olOKMSMJQOqJojxbeheBNpXa-6bQfFEZqcq4mqWoSrPbOx8jtob3PO1MeA_-SyS-fQIAk</recordid><startdate>20210701</startdate><enddate>20210701</enddate><creator>Pan, Qi</creator><creator>Li, Kaixuan</creator><creator>Cheng, Xiaoyi</creator><creator>Chen, Lin</creator><creator>Yu, Qi</creator><creator>Fan, HengXin</creator><creator>Zheng, Liang</creator><creator>Yang, Zihua</creator><creator>Ni, Feng</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-8542-0925</orcidid></search><sort><creationdate>20210701</creationdate><title>A photoactivatable antibody-Chlorin e6 conjugate enabling singlet oxygen production for tumor-targeting photodynamic therapy</title><author>Pan, Qi ; Li, Kaixuan ; Cheng, Xiaoyi ; Chen, Lin ; Yu, Qi ; Fan, HengXin ; Zheng, Liang ; Yang, Zihua ; Ni, Feng</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c341t-d96a48b39e145058aa868fe99618942d0034185cdfd698fb5f75040b46bc03a13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Animals</topic><topic>Apoptosis - drug effects</topic><topic>B7-H1 Antigen - metabolism</topic><topic>Cell Line</topic><topic>Chlorophyllides - chemistry</topic><topic>Chlorophyllides - pharmacokinetics</topic><topic>Female</topic><topic>HCT116 Cells</topic><topic>Humans</topic><topic>Immunoconjugates - chemistry</topic><topic>Immunoconjugates - pharmacokinetics</topic><topic>Mice</topic><topic>Mice, Nude</topic><topic>Optical Imaging</topic><topic>Photochemotherapy - methods</topic><topic>Singlet Oxygen - metabolism</topic><topic>Singlet Oxygen - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pan, Qi</creatorcontrib><creatorcontrib>Li, Kaixuan</creatorcontrib><creatorcontrib>Cheng, Xiaoyi</creatorcontrib><creatorcontrib>Chen, Lin</creatorcontrib><creatorcontrib>Yu, Qi</creatorcontrib><creatorcontrib>Fan, HengXin</creatorcontrib><creatorcontrib>Zheng, Liang</creatorcontrib><creatorcontrib>Yang, Zihua</creatorcontrib><creatorcontrib>Ni, Feng</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Biomedical materials (Bristol)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pan, Qi</au><au>Li, Kaixuan</au><au>Cheng, Xiaoyi</au><au>Chen, Lin</au><au>Yu, Qi</au><au>Fan, HengXin</au><au>Zheng, Liang</au><au>Yang, Zihua</au><au>Ni, Feng</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A photoactivatable antibody-Chlorin e6 conjugate enabling singlet oxygen production for tumor-targeting photodynamic therapy</atitle><jtitle>Biomedical materials (Bristol)</jtitle><addtitle>Biomed Mater</addtitle><date>2021-07-01</date><risdate>2021</risdate><volume>16</volume><issue>4</issue><spage>45003</spage><pages>45003-</pages><issn>1748-6041</issn><eissn>1748-605X</eissn><abstract>Photodynamic therapy is a new technology for disease diagnosis and treatment in modern medical clinics. The main advantages of photodynamic therapy are low toxicity and side effects, a wide range of applications, no drug resistance, and no obvious trauma in the treatment process. However, to achieve effective photodynamic therapy, new photosensitizer carriers need to be constructed, which can selectively deliver photosensitizers into tumor tissues. In this work, a photoactivatable antibody-Chlorin e6 conjugate with a dual-function to target tumor tissue and realize cancer photodynamic therapy is constructed. Both and experiments indicate that the antibody-Chlorin e6 conjugate has the ability to target tumors rapidly and efficiently, and has the ability to generate reactive oxygen species and kill tumor cells. Overall, this photoactivable antibody-Chlorin e6 conjugate may provide a promising strategy to address the current challenges of cancer photodynamic therapy.</abstract><cop>England</cop><pmid>32584266</pmid><doi>10.1088/1748-605X/ab9f57</doi><orcidid>https://orcid.org/0000-0001-8542-0925</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1748-6041
ispartof Biomedical materials (Bristol), 2021-07, Vol.16 (4), p.45003
issn 1748-6041
1748-605X
language eng
recordid cdi_proquest_miscellaneous_2417393502
source MEDLINE; IOP Publishing Journals; Institute of Physics (IOP) Journals - HEAL-Link
subjects Animals
Apoptosis - drug effects
B7-H1 Antigen - metabolism
Cell Line
Chlorophyllides - chemistry
Chlorophyllides - pharmacokinetics
Female
HCT116 Cells
Humans
Immunoconjugates - chemistry
Immunoconjugates - pharmacokinetics
Mice
Mice, Nude
Optical Imaging
Photochemotherapy - methods
Singlet Oxygen - metabolism
Singlet Oxygen - pharmacology
title A photoactivatable antibody-Chlorin e6 conjugate enabling singlet oxygen production for tumor-targeting photodynamic therapy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T03%3A12%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20photoactivatable%20antibody-Chlorin%20e6%20conjugate%20enabling%20singlet%20oxygen%20production%20for%20tumor-targeting%20photodynamic%20therapy&rft.jtitle=Biomedical%20materials%20(Bristol)&rft.au=Pan,%20Qi&rft.date=2021-07-01&rft.volume=16&rft.issue=4&rft.spage=45003&rft.pages=45003-&rft.issn=1748-6041&rft.eissn=1748-605X&rft_id=info:doi/10.1088/1748-605X/ab9f57&rft_dat=%3Cproquest_cross%3E2417393502%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2417393502&rft_id=info:pmid/32584266&rfr_iscdi=true